Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Hypersensitivity | 11 | 2022 | 917 | 2.080 |
Why?
|
| Anaphylaxis | 6 | 2022 | 757 | 1.300 |
Why?
|
| International Classification of Diseases | 3 | 2019 | 909 | 0.780 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2022 | 345 | 0.670 |
Why?
|
| Allergy and Immunology | 4 | 2024 | 176 | 0.580 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2015 | 273 | 0.420 |
Why?
|
| Skin Tests | 5 | 2022 | 637 | 0.390 |
Why?
|
| Allergens | 2 | 2018 | 1410 | 0.390 |
Why?
|
| Hypersensitivity | 3 | 2021 | 1158 | 0.300 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2021 | 2273 | 0.260 |
Why?
|
| Viral Vaccines | 2 | 2022 | 596 | 0.260 |
Why?
|
| Fas Ligand Protein | 6 | 2011 | 216 | 0.250 |
Why?
|
| Aspirin | 2 | 2021 | 3134 | 0.230 |
Why?
|
| Immunologic Tests | 2 | 2015 | 103 | 0.230 |
Why?
|
| Pharmaceutical Preparations | 3 | 2019 | 1088 | 0.230 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 619 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7409 | 0.180 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2021 | 147 | 0.170 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 1230 | 0.160 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2021 | 202 | 0.150 |
Why?
|
| Urticaria | 1 | 2018 | 150 | 0.140 |
Why?
|
| Angioedema | 1 | 2018 | 191 | 0.140 |
Why?
|
| Dermatitis | 1 | 2018 | 201 | 0.130 |
Why?
|
| Immunoglobulin E | 1 | 2022 | 1495 | 0.130 |
Why?
|
| Denmark | 1 | 2018 | 771 | 0.130 |
Why?
|
| Eye Neoplasms | 3 | 2007 | 307 | 0.130 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2015 | 490 | 0.110 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5490 | 0.110 |
Why?
|
| Membrane Glycoproteins | 4 | 2005 | 3702 | 0.100 |
Why?
|
| Vaccines | 1 | 2021 | 837 | 0.100 |
Why?
|
| Leukemia L5178 | 3 | 2007 | 14 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4370 | 0.100 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 997 | 0.090 |
Why?
|
| Medical Records | 1 | 2015 | 1407 | 0.090 |
Why?
|
| Neutrophils | 3 | 2020 | 3766 | 0.080 |
Why?
|
| Apoptosis | 2 | 2004 | 9488 | 0.080 |
Why?
|
| Humans | 26 | 2024 | 761423 | 0.070 |
Why?
|
| Disease Management | 2 | 2015 | 2507 | 0.070 |
Why?
|
| Inpatients | 1 | 2018 | 2548 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2022 | 12796 | 0.070 |
Why?
|
| Skin Diseases | 1 | 2015 | 1093 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2011 | 3687 | 0.060 |
Why?
|
| Cytokines | 1 | 2020 | 7392 | 0.060 |
Why?
|
| Retinal Ganglion Cells | 1 | 2011 | 811 | 0.060 |
Why?
|
| Textbooks as Topic | 1 | 2024 | 19 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20093 | 0.060 |
Why?
|
| Anesthesia | 1 | 2014 | 1594 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2004 | 677 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2005 | 3061 | 0.050 |
Why?
|
| Glaucoma | 1 | 2011 | 1185 | 0.050 |
Why?
|
| Excipients | 1 | 2021 | 98 | 0.050 |
Why?
|
| Mice, Inbred DBA | 3 | 2007 | 621 | 0.040 |
Why?
|
| Female | 12 | 2021 | 392581 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 348 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2004 | 1037 | 0.040 |
Why?
|
| Middle Aged | 6 | 2021 | 220826 | 0.040 |
Why?
|
| Curriculum | 2 | 2024 | 3741 | 0.040 |
Why?
|
| Eye | 1 | 2002 | 711 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2021 | 859 | 0.040 |
Why?
|
| Male | 9 | 2021 | 360736 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13502 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 4912 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2020 | 857 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2021 | 565 | 0.030 |
Why?
|
| Teaching | 1 | 2024 | 1169 | 0.030 |
Why?
|
| Adult | 4 | 2021 | 221148 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 7874 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 6215 | 0.030 |
Why?
|
| Boston | 2 | 2020 | 9330 | 0.030 |
Why?
|
| Learning | 1 | 2024 | 1740 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2021 | 1732 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1597 | 0.030 |
Why?
|
| Anterior Chamber | 2 | 2005 | 194 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 59207 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2021 | 2124 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 22164 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1876 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1664 | 0.030 |
Why?
|
| United States | 2 | 2020 | 72339 | 0.020 |
Why?
|
| Aged | 3 | 2021 | 169235 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2019 | 1162 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2011 | 200 | 0.020 |
Why?
|
| Cell Line | 1 | 2004 | 15605 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2005 | 2016 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 4549 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2005 | 4650 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 1091 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3381 | 0.020 |
Why?
|
| Mice | 5 | 2011 | 81509 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 830 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1750 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2011 | 708 | 0.020 |
Why?
|
| Ligands | 2 | 2005 | 3271 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 80582 | 0.020 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 413 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2020 | 6238 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2005 | 6132 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1677 | 0.020 |
Why?
|
| Animals | 6 | 2011 | 168441 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 427 | 0.010 |
Why?
|
| Phenotype | 1 | 2022 | 16606 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2760 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1529 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2002 | 106 | 0.010 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2002 | 153 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 910 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4811 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10766 | 0.010 |
Why?
|
| Keratitis | 1 | 2005 | 239 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2002 | 365 | 0.010 |
Why?
|
| Microglia | 1 | 2011 | 1361 | 0.010 |
Why?
|
| Aqueous Humor | 1 | 2002 | 153 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 185 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2002 | 190 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2005 | 1351 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 915 | 0.010 |
Why?
|
| Inflammation | 3 | 2007 | 10762 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5775 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4354 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1970 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 14026 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 879 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41446 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1249 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9352 | 0.010 |
Why?
|
| Chemokines | 1 | 2002 | 959 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2416 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15262 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2002 | 2626 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 5868 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54415 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15838 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 4779 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 23990 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 39975 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18247 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 3819 | 0.010 |
Why?
|
| Macrophages | 1 | 2005 | 5768 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 4320 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2002 | 4445 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 23441 | 0.000 |
Why?
|
| Risk Factors | 1 | 2014 | 74167 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 22163 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_